Home > NRC Library > ADAMS Public Documents

628080 Amendment No. 3 for POINT Biopharma USA, Inc. to License No. 13-35593-01

Accession Number: ML21335A377

Date Released: Wednesday, December 8, 2021

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML21335A316 - 628080 Cover Letter for POINT Biopharma USA, Inc. to License No. 13-35593-01 (4 page(s), 12/1/2021)
• ML21335A312 - 628080 Amendment No. 3 for POINT Biopharma USA, Inc. to License No. 13-35593-01 (7 page(s), 12/1/2021)
• ML21160A110 - Change of Control - POINT Biopharma USA Inc. (3 page(s), 5/20/2021)